Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Participants Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending d…
Type 1 Diabetes MellitusT1DT1DM+7 more
Estimated
~$10 – $8,750
COUR Pharmaceutical Development Company, Inc.NCT06783309
Type 1 Diabetes Extension Study
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Di…
Type 1 Diabetes MellitusT1DMT1D
Estimated
~$10 – $675
National Institute of Allergy and Infectious Diseases (NIAID)NCT02734277
Phase 1
A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus
This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tole…
Diabetes Mellitus, Type 1HypoglycemiaIslet Cell Transplantation+14 more
Estimated
~$10 – $8,750
Otsuka Pharmaceutical Factory, Inc.NCT06575426
Observational
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfa…
Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia
Estimated
~$10 – $6,250
Vanderbilt University Medical CenterNCT06852950